Managed end-to-end clinical research projects across multiple therapeutic areas, adhering to time, quality, and cost constraints. Oversaw the execution of clinical research activities, served as the primary point of contact for clients, and managed contractual deliverables and modifications. Regularly communicated project status, promptly escalated issues, and effectively troubleshooted to ensure client satisfaction.

• Successfully delivered 11 clinical trials covering NORAM, EMEA, and APAC-I regions for a diverse client portfolio, including Big Pharma, Biopharma, and CROs.
• Managed trials spanning Phase I to Phase IV, encompassing oncology, neurology, gastroenterology, tropical diseases, and immunology indications in both adult and pediatric populations, utilizing oral, IV, or SC injection forms for both chemical IMPs and biological ATMPs like mAbs and CAR-T cells.
• Effectively led cross-functional teams and third-party vendors to ensure timely project delivery and compliance with local regulations, ICH GCP guidelines, SOPs, and project-specific plans.
• Prepared and presented study-related updates, dashboards, and reports to study teams, and senior management, as well as sponsors, vendors, and partners.

• Developed feasibility metrics for clinical trials aimed at maximizing patient recruitment rates per country and per site. 
• Conducted retrospective evaluation of Sponsor's projected performance to inform site selection. Utilized benchmark analysis, country analysis, risk assessment, and scenario development to enhance feasibility assessment. 
• Leveraged clinical trials with realistic forecasts and achievable plans to optimize trial outcomes.

• Collaborated closely with in-house strategy consulting teams of pharma and medical device companies to offer comprehensive and unbiased insights into emerging trends, technologies, and markets across pre-clinical, clinical, and post-market approved medicines and medical devices.

• Conducted integral membrane protein overexpression, purification, and characterization using state-of-the-art biochemical and biophysical tools to gain insights into early-stage post-natal brain development

• Conducted RNA deep sequencing to elucidate mechanisms underlying cerebral cortex development.

• Performed genetic assays to study adult brain neurogenesis

• Established a fruit fly disease model for hereditary sensory autonomous neuropathy, a rare genetic disorder.

• Genetically engineered recombinant E. coli strains to produce xylanase enzymes tailored for the animal feed industry.

• Conducted genetic and proteomic analyses aimed at enhancing meat quality for food industry

• Conducted genetic testing within the IVF laboratory.